A Review of the Clinical Progress of CT1812, a Novel Sigma-2 Receptor Antagonist for the Treatment of Alzheimer's Disease. - Steinfield, Sara R.; Stenn, Daniel F.; Chen, Helen; Kalisch, Bettina E. (Pharmaceuticals (14248247), 2025)